| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 4.468 | 56.571 | 69.783 | 62.270 | 76.233 | 87.652 | 96.789 | 103.489 |
| Total Income - EUR | - | - | 4.468 | 56.571 | 69.996 | 62.274 | 76.238 | 87.658 | 97.265 | 104.173 |
| Total Expenses - EUR | - | - | 5.098 | 16.883 | 21.203 | 22.806 | 31.943 | 37.489 | 44.602 | 51.449 |
| Gross Profit/Loss - EUR | - | - | -630 | 39.688 | 48.792 | 39.468 | 44.295 | 50.169 | 52.663 | 52.724 |
| Net Profit/Loss - EUR | - | - | -675 | 39.122 | 48.124 | 38.981 | 43.713 | 49.310 | 51.710 | 49.660 |
| Employees | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Diablife Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 26 | 1.866 | 1.874 | 910 | 1.961 | 1.326 | 1.259 | 638 |
| Current Assets | - | - | 3.587 | 38.061 | 47.658 | 39.975 | 45.921 | 50.841 | 54.082 | 53.280 |
| Inventories | - | - | 0 | 0 | 47 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 1.952 | 3.381 | 6.933 | 6.826 | 28.675 | 23.964 | 36.041 | 22.095 |
| Cash | - | - | 1.635 | 34.680 | 40.677 | 33.149 | 17.246 | 9.641 | 7.203 | 21.133 |
| Shareholders Funds | - | - | -631 | 38.502 | 48.166 | 39.031 | 43.762 | 49.358 | 51.758 | 49.709 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 4.244 | 1.425 | 1.367 | 1.855 | 4.121 | 2.808 | 3.583 | 4.209 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diablife Srl